Неалкогольная жировая болезнь печени, ассоциированная с ожирением: возможности урсодезоксихолевой кислоты

The diagnosis and management of patients with obesity and nonalcoholic fatty liver disease (NAFLD) is now the role and importance of the first contact a doctor (therapist and general practitioner). The article discusses the diagnostic algorithm of obesity, based on the classification AAСE / ACE (2014), and the possibility of ursodeoxycholic acid as part of treatment and prevention recommendations in patients with NAFLD associated with obesity.